Por favor, use este identificador para citar o enlazar este ítem: https://hdl.handle.net/10495/36827
Registro completo de metadatos
Campo DC Valor Lengua/Idioma
dc.contributor.authorZapata Cardona, María Isabel-
dc.contributor.authorFlórez Álvarez, Lizdany-
dc.contributor.authorGómez Gallego, Diana Maryory-
dc.contributor.authorMoncada Díaz, María Juliana-
dc.contributor.authorHernández López, Juan Camilo-
dc.contributor.authorDíaz Castrillón, Francisco Javier-
dc.contributor.authorRugeles López, María Teresa-
dc.contributor.authorAguilar Jiménez, Wbeimar-
dc.contributor.authorZapata Builes, Wildeman-
dc.date.accessioned2023-10-09T15:36:44Z-
dc.date.available2023-10-09T15:36:44Z-
dc.date.issued2022-
dc.identifier.citationZapata-Cardona MI, Flórez-Álvarez L, Gómez-Gallego DM, Moncada-Díaz MJ, Hernandez JC, Díaz F, Rugeles MT, Aguilar-Jiménez W, Zapata W. Comparison among plaque assay, tissue culture infectious dose (TCID50) and real-time RT-PCR for SARS-CoV-2 variants quantification. Iran J Microbiol. 2022 Jun;14(3):291-299. doi: 10.18502/ijm.v14i3.9758. PMID: 37124861; PMCID: PMC10132340.spa
dc.identifier.issn2008-3289-
dc.identifier.urihttps://hdl.handle.net/10495/36827-
dc.description.abstractABSTRACT: SARS-CoV-2 variants of concern (VOC) and interest (VOI) pose a significant threat to pub lic health because the rapid change in the SARS-CoV-2 genome can alter viral phenotypes such as virulence, transmissi bility and the ability to evade the host response. Hence, SARS-CoV-2 quantification techniques are essential for timely diagnosis and follow-up. Besides, they are vital to understanding viral pathogenesis, antiviral evaluation, and vaccine de velopment. Materials and Methods: Five isolates of SARS-CoV-2: D614G strain (B.1), three VOC (Alpha, Gamma and Delta), and one VOI (Mu) were used to compare three techniques for viral quantification, plaque assay, median tissue culture infectious dose (TCID ) and real-time RT-PCR. Results: Plaque assay showed viral titers between 0.15 ± 0.01×107 and 1.95 ± 0.09×107 PFU/mL while viral titer by TCID assay was between 0.71 ± 0.01×106 to 4.94 ± 0.80×106 TCID /mL for the five SARS-CoV-2 isolates. The PFU/mL titer obtained by plaque and the calculated from TCID assays differed by 0.61 log10, 0.59 log10, 0.59 log10 and 0.96 log10 for Alfa, Gamma, Delta, and Mu variants (p≤0.0007), respectively. No differences were observed for the D614G strain. Real-time PCR assay exhibited titers ranging from 0.39 ± 0.001×108 to 3.38 ± 0.04×108 RNA copies/µL for all variants. The relation between PFU/mL and RNA copies/mL was 1:29800 for D614G strain, 1:11700 for Alpha, 1:8930 for Gamma,1:12500 for Delta, and 1:2950 for Mu.Conclusion: TCID assay was comparable to plaque assay for D614G but not for others SARS-CoV-2 variants. Our data demonstrated a correlation among PFU/mL and E gene RNA copies/µL, units of measure commonly used to quantify the viral load in diagnostic and research fields. The results suggest that the proportion of infectious virions in vitro changes de pending on the SARS-CoV-2 variant, being Mu, the variant reaching a higher viral titer with fewer viral copies.spa
dc.format.extent9spa
dc.format.mimetypeapplication/pdfspa
dc.language.isoengspa
dc.publisherTehran : Tehran University of Medical Sciencesspa
dc.type.hasversioninfo:eu-repo/semantics/publishedVersionspa
dc.rightsinfo:eu-repo/semantics/openAccessspa
dc.rights.urihttp://creativecommons.org/licenses/by-nc/2.5/co/*
dc.titleComparison among plaque assay, tissue culture infectious dose (TCID) 50 and real-time RT-PCR for SARS-CoV-2 variants quantificationspa
dc.typeinfo:eu-repo/semantics/articlespa
dc.publisher.groupInmunovirologíaspa
dc.publisher.groupPrograma de Estudio y Control de Enfermedades Tropicales (PECET)spa
dc.identifier.doi10.18502/ijm.v14i3.9758-
oaire.versionhttp://purl.org/coar/version/c_970fb48d4fbd8a85spa
dc.rights.accessrightshttp://purl.org/coar/access_right/c_abf2spa
dc.identifier.eissn2008-4447-
oaire.citationtitleIranian Journal of Microbiologyspa
oaire.citationstartpage291spa
oaire.citationendpage299spa
oaire.citationvolume14spa
oaire.citationissue3spa
dc.rights.creativecommonshttps://creativecommons.org/licenses/by-nc/4.0/spa
dc.publisher.placeIranspa
dc.type.coarhttp://purl.org/coar/resource_type/c_2df8fbb1spa
dc.type.redcolhttps://purl.org/redcol/resource_type/ARTspa
dc.type.localArtículo de investigaciónspa
dc.subject.decsSARS-CoV-2-
dc.subject.decsCarga Viral-
dc.subject.decsViral Load-
dc.subject.decsEnsayo de Placa Viral-
dc.subject.decsViral Plaque Assay-
dc.subject.decsDesarrollo de Vacunas-
dc.subject.decsVaccine Development-
dc.subject.decsEnsayos Clínicos como Asunto-
dc.subject.decsClinical Trials as Topic-
dc.subject.decsReacción en Cadena de la Polimerasa-
dc.subject.decsPolymerase Chain Reaction-
dc.description.researchgroupidCOL0012444spa
dc.description.researchgroupidCOL0015099spa
dc.relation.ispartofjournalabbrevIran. J. Microbiol.spa
Aparece en las colecciones: Artículos de Revista en Ciencias Médicas

Ficheros en este ítem:
Fichero Descripción Tamaño Formato  
ZapataMaria_2022_ComparisonAmongPlaqueAssay.pdfArtículo de Investigación974.56 kBAdobe PDFVisualizar/Abrir


Este ítem está sujeto a una licencia Creative Commons Licencia Creative Commons Creative Commons